Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5803)
All Articles published online
|
Publishing Process of This Article
|
Jul 16, 2022 (publication date) through Sep 16, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Herold Z, Herold M, Lohinszky J, Szasz AM, Dank M, Somogyi A. Longitudinal changes in personalized platelet count metrics are good indicators of initial 3-year outcome in colorectal cancer. World J Clin Cases 2022; 10(20): 6825-6844 [PMID: 36051133 DOI: 10.12998/wjcc.v10.i20.6825] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i20/6825.htm |
| Number | Citing Articles |
| 1 |
Zeng Wang, Sining Zhao, Xuan Zhang, Xinyi Mao, Guonong Yang, Meiqin Yuan, Xiaofang Zhou. Effect of prognostic nutritional index on laboratory parameters and survival in metastatic colorectal cancer patients treated with fruquintinib: a retrospective study. PeerJ 2024; 12: e18565 doi: 10.7717/peerj.18565
|
| 2 |
Zoltan Herold, Magdolna Herold, Gyongyver Szentmartoni, Reka Szalasy, Julia Lohinszky, Aniko Somogyi, Attila Marcell Szasz, Magdolna Dank. Are Calculated Immune Markers with or Without Comorbidities Good Predictors of Colorectal Cancer Survival? The Results of a Longitudinal Study. Medical Sciences 2025; 13(3): 108 doi: 10.3390/medsci13030108
|
| 3 |
心艳 林. Research Progress of HPR, PLR, NLR and CEA in Colorectal Cancer. Advances in Clinical Medicine 2025; 15(09): 169 doi: 10.12677/acm.2025.1592471
|
| 4 |
Ralf Kleef, Magdolna Dank, Magdolna Herold, Emese Irma Agoston, Julia Lohinszky, Emoke Martinek, Zoltan Herold, Attila Marcell Szasz. Comparison of the effectiveness of integrative immunomodulatory treatments and conventional therapies on the survival of selected gastrointestinal cancer patients. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-47802-5
|
| 5 |
Eugeniy Smorodin, Valentin Chuzmarov, Toomas Veidebaum. The Potential of Integrative Cancer Treatment Using Melatonin and the Challenge of Heterogeneity in Population-Based Studies: A Case Report of Colon Cancer and a Literature Review. Current Oncology 2024; 31(4): 1994 doi: 10.3390/curroncol31040149
|
| 6 |
Alfonso Martín-Carnicero, Enrique Ramalle-Gomara, Susana Rubio-Mediavilla, Martina Alonso-Lago, Miriam Zorrilla-Larraga, Isabel Manrique-Abós, María E. de las Heras-Dueña, Ignacio M. Larrayoz, Alfredo Martínez. Prognostic and Predictive Biomarkers in Patients with Locally Advanced Rectal Cancer (LARC) Treated with Preoperative Chemoradiotherapy. Journal of Clinical Medicine 2022; 11(20): 6091 doi: 10.3390/jcm11206091
|
| 7 |
Aleksandra Misiewicz, Violetta Dymicka-Piekarska. Fashionable, but What is Their Real Clinical Usefulness? NLR, LMR, and PLR as a Promising Indicator in Colorectal Cancer Prognosis: A Systematic Review. Journal of Inflammation Research 2023; : 69 doi: 10.2147/JIR.S391932
|
| 8 |
Pırıltı Özcan, Özgül Düzgün. The Importance of Preoperative NLR, PLR, and MPV Values in Predicting the Risk of Complications in Colorectal Peritoneal Carcinomatosis. Journal of Personalized Medicine 2024; 14(9): 916 doi: 10.3390/jpm14090916
|